ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment,…
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
February 14, 2025 16:05 ET | Source: Dyne Therapeutics, Inc. - Data…
Correction – Diagnos Announces Closing of Private Placement
In the original press release dated February 5, 2025, announcing the closing…
Worldwide Silicon Wafer Shipments and Revenue Start Recovery in Late 2024, SEMI Reports
MILPITAS, Calif., Feb. 13, 2025 /PRNewswire/ -- In the second half of…
Correction: GUERBET : Financial agenda for 2025
CORRECTION - Financial agenda for 2025 Villepinte, 13 janvier 2025: Guerbet (FR0000032526…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,…
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access…